The Patent Finder

Universite de Montreal

39 patents currently held · Updated Nov 21, 2026
54 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 6 name spellings.

0
Ending by 2030
Feb 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Dec 18 to 25, 2026 · next Dec 18
  • 4 fees due Jan 2 to 18, 2027 · next Jan 2
  • 1 fee due Feb 15, 2027
    The maintenance fee for Selection of human hematopoetic stem cells using EPCR (US 11,725,187) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 1 fee due Mar 19, 2027
    The maintenance fee for Heterocyclic Mitochondrial Activity Inhibitors and Uses Thereof (US 11,760,754) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.
  • 1 fee due Jun 8, 2027
    The maintenance fee for Dynamic Shoulder Orthosis with Rehabilitating Adduction (US 9,204,989) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
  • 1 fee due Jul 23, 2027
    The maintenance fee for Cyclic peptides and uses thereof (US 11,879,021) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.
  • 1 fee due Sep 10, 2027
    The maintenance fee for Renilla based biosensors for monitoring biomolecule localization and trafficking in cells (US 10,584,159) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Compounds and use thereof in the expansion of hematopoietic stem cells and/or hematopoietic progenitor cells (US 10,647,718) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026
  • 3 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,815,944Pharmaceutical composition with gelling properties containing a tyrosine derivative
In force
 · USPTO record
In forceUSPTO record
US 9,029,097Biosensors for Monitoring Receptor-Mediated G-Protein Activation
In force
 · High confidence
In forceHigh confidence
US 9,018,395Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
In force
 · USPTO record
In forceUSPTO record
US 10,342,817Combination therapy using ribavirin as elF4E inhibitor
In force
 · USPTO record
In forceUSPTO record
US 9,409,906Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
In force
 · USPTO record
In forceUSPTO record
US 10,336,747Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
In force
 · USPTO record
In forceUSPTO record
US 9,545,416Combination therapy using ribavirin as eIF4E inhibitor
In force
 · USPTO record
In forceUSPTO record
US 9,204,989Dynamic Shoulder Orthosis with Rehabilitating Adduction
In force
 · High confidence
In forceHigh confidence
US 10,324,085Systems and methods for the monitoring of protein complex formation in cells
In force
 · USPTO record
In forceUSPTO record
US 9,598,419Imidazotriazine and imidazodiazine compounds
In force
 · USPTO record
In forceUSPTO record
10 of 39 patents shown.
Pro members see all 39.
Pro members: see all 39 patents
Also on record, not counted in the 39: 54 patents in force now held by others · 94 lapsed for an unpaid fee · 115 ended at full term · 1 past the fee grace period · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

14 pending · 18 abandoned · 46 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited